Oregon Clinical and Translational Research Institute
Oregon Clinical and Translational Research Institute
批准号:
10693308
负责人:
David H Ellison
金额:
$967.3万
依托单位国家:
美国
项目类别:
财政年份:
2017
资助国家:
美国
项目状态:
未结题
起止时间:
2017-09-02 至 2027-07-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Overall - Project Summary
The Oregon Clinical and Translational Research Institute (OCTRI) is a mature CTSA hub that has been
accelerating research at Oregon Health & Science University (OHSU) since 2006. It has a stable, yet nimble,
leadership structure that has functioned efficiently during the current funding cycle to meet its goals. OCTRI
benefits from the guidance of several advisory groups in evaluation and planning and will use their input to
continuously improve its structure. OCTRI’s many effective programs assist investigators and trainees by
providing support services and fostering novel approaches to improve health in Oregon and beyond. OCTRI
will now build on these strengths, while broadening its reach, to address goals that align with the national
priorities articulated by NCATS and solidify its role within the CTSA network. OCTRI has developed nationally
recognized programs to build the translational workforce, and will strengthen this base to bring more diversity,
while also ensuring rigorous competencies are met. OCTRI has developed a regional reputation for leading
innovation and have incorporated these assets in an optional function with the Knight Cancer Institute that
supports the development of new therapeutics. OCTRI has built trust and capacity in research throughout rural
Oregon and will now extend these efforts to the Portland metropolitan region. OCTRI’s current optional function
has amplified the patient voice in research, and it will now be integrated into the community program in order to
extend its reach. OCTRI has led in the development of national informatics platforms and will now leverage
those to build internal support processes throughout OHSU to democratize these resources. At the same time,
OCTRI has recognized limitations with regard to data sharing and will develop a novel optional function to
incorporate Fast Healthcare Interoperability Resources to translate social determinants of health across
electronic systems. OCTRI has been at the forefront of innovative outcome evaluation and will fully implement
the Translational Science Benefits Model. These goals will be accomplished by engaging diverse stakeholders,
by partnering with OHSU investigators, community coalitions, and business enterprises, and by fostering team
science. Through these efforts, OCTRI will become even more essential for OHSU, for Oregon, and for the
nation.
期刊论文(319)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.1002/jbmr.4619
发表时间:
2022-08
期刊:
JOURNAL OF BONE AND MINERAL RESEARCH
影响因子:
6.2
作者:
[Alajlouni, Dima A., Bliuc, Dana, Tran, Thach S., Blank, Robert D., Cawthon, Peggy M., Ensrud, Kristine E., Lane, Nancy E., Orwoll, Eric S., Cauley, Jane A., Center, Jacqueline R.]
通讯作者:
Center, Jacqueline R.
DOI:
10.1016/j.chiabu.2021.105450
发表时间:
2022-08
期刊:
Child abuse & neglect
影响因子:
4.8
作者:
[Hails KA, Petts RA, Hostutler CA, Simoni M, Greene R, Snider TC, Riley AR]
通讯作者:
Riley AR
DOI:
10.3390/s23249860
发表时间:
2023-12-16
期刊:
Sensors (Basel, Switzerland)
影响因子:
--
作者:
[Campbell KR, Wilhelm JL, Antonellis P, Scanlan KT, Pettigrew NC, Martini DN, Chesnutt JC, King LA]
通讯作者:
King LA
DOI:
10.1210/jc.2018-00276
发表时间:
2018-05
期刊:
The Journal of clinical endocrinology and metabolism
影响因子:
--
作者:
[M. Samuels]
通讯作者:
M. Samuels
DOI:
10.1002/onco.13674
发表时间:
2021-04
期刊:
The oncologist
影响因子:
--
作者:
[George S, Jones RL, Bauer S, Kang YK, Schöffski P, Eskens F, Mir O, Cassier PA, Serrano C, Tap WD, Trent J, Rutkowski P, Patel S, Chawla SP, Meiri E, Gordon M, Zhou T, Roche M, Heinrich MC, von Mehren M]
通讯作者:
von Mehren M
共 183 条
Core-003
-
批准号:10198072
-
项目类别:
-
资助金额:$93.68万
-
财政年份:2017
-
负责人:David H Ellison
-
依托单位:
Admin-Core-001
-
批准号:10198069
-
项目类别:
-
资助金额:$90.49万
-
财政年份:2017
-
负责人:David H Ellison
-
依托单位:
Oregon Clinical and Translational Research Institute Quality Assurance and Quality Control Project
-
批准号:10158949
-
项目类别:
-
资助金额:$14.93万
-
财政年份:2017
-
负责人:David H Ellison
-
依托单位:
Oregon Clinical and Translational Research Institute
-
批准号:10198068
-
项目类别:
-
资助金额:$630.8万
-
财政年份:2017
-
负责人:David H Ellison
-
依托单位:
Core-005
-
批准号:10198074
-
项目类别:
-
资助金额:$164.5万
-
财政年份:2017
-
负责人:David H Ellison
-
依托单位:
Oregon Clinical and Translational Research Institute
-
批准号:9514362
-
项目类别:
-
资助金额:$616.99万
-
财政年份:2017
-
负责人:David H Ellison
-
依托单位:
Oregon Clinical and Translational Research Institute - The National COVID Cohort Collaborative (N3C)
-
批准号:10179888
-
项目类别:
-
资助金额:$10.0万
-
财政年份:2017
-
负责人:David H Ellison
-
依托单位:
Core-001
-
批准号:10198070
-
项目类别:
-
资助金额:$68.71万
-
财政年份:2017
-
负责人:David H Ellison
-
依托单位:
Core-002
-
批准号:10198071
-
项目类别:
-
资助金额:$41.36万
-
财政年份:2017
-
负责人:David H Ellison
-
依托单位:
Oregon Clinical and Translational Research Institute - Evaluation of OCTRI's Response to COVID-19
-
批准号:10158990
-
项目类别:
-
资助金额:$9.35万
-
财政年份:2017
-
负责人:David H Ellison
-
依托单位:
Oregon Clinical and Translational Research Institute
-
批准号:10675189
-
项目类别:
-
资助金额:$967.3万
-
财政年份:2017
-
负责人:David H Ellison
-
依托单位:
Core-007
-
批准号:10198076
-
项目类别:
-
资助金额:$36.75万
-
财政年份:2017
-
负责人:David H Ellison
-
依托单位:
Core-006
-
批准号:10198075
-
项目类别:
-
资助金额:$65.22万
-
财政年份:2017
-
负责人:David H Ellison
-
依托单位:
Core-004
-
批准号:10198073
-
项目类别:
-
资助金额:$70.08万
-
财政年份:2017
-
负责人:David H Ellison
-
依托单位:
Oregon Clinical and Translational Research Institute
-
批准号:9977301
-
项目类别:
-
资助金额:$633.75万
-
财政年份:2017
-
负责人:David H Ellison
-
依托单位:
Oregon Clinical and Translational Research Institute
-
批准号:9816556
-
项目类别:
-
资助金额:$17.88万
-
财政年份:2017
-
负责人:David H Ellison
-
依托单位:
Renal Effects of Aldosterone
-
批准号:10266000
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2014
-
负责人:David H Ellison
-
依托单位:
Renal and extrarenal toxicity of aldosterone
-
批准号:9280815
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2014
-
负责人:David H Ellison
-
依托单位:
Renal and extrarenal toxicity of aldosterone
-
批准号:8635009
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2014
-
负责人:David H Ellison
-
依托单位:
Molecular pathogenesis of calcineurin inhibitor-induced hypertension
-
批准号:8549218
-
项目类别:
-
资助金额:$35.68万
-
财政年份:2012
-
负责人:David H Ellison
-
依托单位:
国内基金
海外基金
Molecular Interaction Reconstruction of Rheumatoid Arthritis Therapies Using Clinical Data
-
批准号:31070748
-
项目类别:面上项目
-
资助金额:34.0万元
-
批准年份:2010
-
负责人:Christine Nardini
-
依托单位: